Risk evaluation of endoscopic retrograde cholangiopancreatography for elder patients
10.3760/cma.j.issn.1007-5232.2017.04.012
- VernacularTitle:高龄患者经内镜逆行胰胆管造影术的风险评价
- Author:
Yuanyuan LI
;
Guohua LI
;
Youxiang CHEN
;
Xiaojiang ZHOU
;
Yong ZHU
;
Hao ZENG
;
Nonghua LYU
- Keywords:
Cholangiopancreatography,endoscopic retrograde;
Safety;
Complications
- From:
Chinese Journal of Digestive Endoscopy
2017;34(4):274-276
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the safety of endoscopic retrograde cholangiopancreatography (ERCP) for elder patients (age more than or equal to 80 years).Methods Data of 464 patients (age ≥ 80 years) who underwent ERCP procedures from June 2008 to June 2014 in the First Affiliated Hospital of Nanchang University were compared with those of patients less than or equal to 60 years old,randomly chosen at 1∶4,for comorbidity,feature of disease distribution,intraoperative situation and postoperative complications of ERCP.Results The comorbidity rates of coronary heart disease,hypertension,chronic pulmonary disease and type 2 diabetes in observation group were significantly higher than those in the control group(P＜0.05),but there was no significant difference between two groups regarding to the comorbidity rate of arrhythmia(P =0.111).The main feature of disease distribution in two groups was choledocholithiasis,but the rate of malignant tumor in observation group was higher than that in the control group(P＜0.05).The success rate of ERCP showed no significant difference in two groups (98.92％ VS 99.35％,P=0.358).There was no significant difference between the two groups in the complication rates of acute pancreatitis (4.96％ VS 3.18％,P =0.064),infection (0.43％ VS 0.54％,P =1.000) and hemorrhage (1.08％ VS 0.59％,P=0.259).However the rate of perforation in observation group was lower than that in the control group (0.43％ VS 0.05％,P =0.043).Conclusion ERCP is safe and effective for elder patients.
